Syzygy Biotech Nabs $100K Investment for PCR Reagent Development

Syzygy, which manufactures low-cost reagents for DNA amplification, has received an investment from the Michigan Pre-Seed Capital Fund.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.